Millennium Pharmaceuticals Inc. v. Actavis LLC

Application Number	Patent Number	External Links
-	US6713446	Espacenet Google Patents

COMPLAINT filed against Actavis LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1906377) - filed by Millennium Pharmaceuticals Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 04/04/2016)

2016-04-04

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (klc) (Entered: 04/04/2016)

2016-04-04

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 22, 2016. Date of Expiration of Patent: January 25, 2022.Thirty Month Stay Deadline: 8/22/2018. (klc) (Entered: 04/04/2016)

2016-04-04

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number: 6,713,446 B2. (klc) (Entered: 04/04/2016)

2016-04-04

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceuticals Company Limited for Millennium Pharmaceuticals Inc. - filed by Millennium Pharmaceuticals Inc. (klc) (Entered: 04/04/2016)

2016-04-04

1

View

SUMMONS Returned Executed by Millennium Pharmaceuticals Inc.. Actavis LLC served on 4/4/2016, answer due 4/25/2016. (Noreika, Maryellen) (Entered: 04/04/2016)

2016-04-04

1

View

Summons Issued with Magistrate Consent Notice attached as to Actavis LLC on 4/4/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (klc)

2016-04-04

1

No Actions

Summons Issued

2016-04-04

1

No Actions

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)

2016-04-06

1

No Actions

Case Assigned/Reassigned

2016-04-06

1

No Actions

ANSWER to 1 Complaint, COUNTERCLAIM against Millennium Pharmaceuticals Inc. by Actavis LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Patent/Trademark Report)(Fineman, Steven) (Entered: 04/25/2016)

2016-04-25

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Actavis LLC filed by Actavis LLC. (Fineman, Steven) (Entered: 04/25/2016)

2016-04-25

1

View

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 4/26/2016. (asw) (Entered: 04/26/2016)

2016-04-26

1

View

NOTICE of Appearance by Jason James Rawnsley on behalf of Actavis LLC (Rawnsley, Jason) (Entered: 05/13/2016)

2016-05-13

1

View

MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Robyn Ast-Gmoser, Mark Deming and Khurram Naik - filed by Actavis LLC. (Rawnsley, Jason) (Entered: 05/13/2016)

2016-05-13

1

Download

ANSWER to 7 Answer to Complaint, Counterclaim by Millennium Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 05/16/2016)

2016-05-16

1

View

SO ORDERED - re 11 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Robyn Ast-Gmoser, Mark Deming and Khurram Naik filed by Actavis LLC. Ordered by Judge Gregory M. Sleet on 5/17/2016. (mdb)

2016-05-17

1

No Actions

SO ORDERED

2016-05-17

1

No Actions

Pro Hac Vice Attorney Mark T. Deming, Gary E. Hood for Actavis LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)

2016-05-18

1

No Actions

Pro Hac Vice Attorney Khurram Naik for Actavis LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)

2016-05-18

1

No Actions

Add Attorneys - PHV only

2016-05-18

1

No Actions

STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 9, 2016 - filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 05/25/2016)

2016-05-25

1

View

SO ORDERED

2016-05-27

1

No Actions

SO ORDERED - re 13 STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 9, 2016 filed by Millennium Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 5/27/2016. (mdb)

2016-05-27

1

No Actions

Add Attorneys - PHV only

2016-05-31

1

No Actions

Pro Hac Vice Attorney Robyn H. Ast-Gmoser for Actavis LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2016-05-31

1

No Actions

STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 15, 2016 - filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/08/2016)

2016-06-08

1

View

SO ORDERED

2016-06-09

1

No Actions

SO ORDERED - re 14 STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 15, 2016 filed by Millennium Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 6/9/2016. (mdb)

2016-06-09

1

No Actions

Joint STATUS REPORT [Rule 16] by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) Modified on 6/16/2016 (mdb). (Entered: 06/15/2016)

2016-06-15

1

View

ORAL ORDER - re 15 Joint Status Report: The plaintiff's request to submit a proposed schedule by July 13, 2016 is GRANTED. Ordered by Judge Gregory M. Sleet on 6/30/2016. (mdb)

2016-06-30

1

No Actions

Oral Order

2016-06-30

1

No Actions

PROPOSED ORDER -- Scheduling Order -- by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 07/13/2016)

2016-07-13

1

View

NOTICE OF SERVICE of Plaintiff Millennium Pharmaceuticals, Inc.'s Rule 26(a) Initial Disclosures filed by Millennium Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 09/02/2016)

2016-09-02

1

Download

NOTICE OF SERVICE of Actavis LLC's Rule 26(a) Initial Disclosures filed by Actavis LLC.(Rawnsley, Jason) (Entered: 09/02/2016)

2016-09-02

1

Download

ORAL ORDER SCHEDULING A TELECONFERENCE: A Teleconference to discuss the schedule in this matter has been set for Monday, September 12, 2016, at 2:00 PM with the Honorable Gregory M. Sleet. Counsel for plaintiff(s) is directed to arrange the conference call and contact chambers at (302) 573-4559 once all the participants are on the line. Ordered by Judge Gregory M. Sleet on 9/8/2016. (ctd)

2016-09-08

1

No Actions

Order Setting Teleconference AND Oral Order

2016-09-08

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Status Conference held on 9/12/2016. Discussion regarding the differences of view presented in the Joint Status Report ( 15 ) as to how this case should proceed while the appeal in relate C.A. No. 12-1011 (GMS) is pending. The parties will attempt to come to an agreement. A Telephone Status Conference is set for 10/12/2016 at 2:00 PM to discuss the status of these discussions and the parties' positions. The plaintiff is directed to arrange the call and to contact Chambers at (302) 573-4559 once all parties are on the line. Should an agreement be reached prior to the teleconference, the parties may file a stipulation for the judge's approval. (Court Reporter Kevin Maurer.) (mdb)

2016-09-12

1

No Actions

~Util - Set Deadlines/Hearings AND Telephone Conference

2016-09-12

1

No Actions

STIPULATION Requesting Stay by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 10/10/2016)

2016-10-10

1

Download

SO ORDERED - re 19 Stipulation Requesting Stay. CASE STAYED. Signed by Judge Gregory M. Sleet on 10/11/2016. (mdb) (Entered: 10/11/2016)

2016-10-11

1

Download

Remark - The telephone conference set for Wednesday, October 12, 2016 at 2:00 PM has been removed from the Court's calendar. (mdb)

2016-10-11

1

No Actions

Remark

2016-10-11

1

No Actions

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis LLC filed by Actavis LLC. (Rawnsley, Jason) (Entered: 10/18/2016)

2016-10-18

1

Download

NOTICE requesting Clerk to remove Robyn Ast-Gmoser as co-counsel. Reason for request: leaving firm. (Rawnsley, Jason) (Entered: 12/15/2017)

2017-12-15

1

View

NOTICE requesting Clerk to remove Khurram Naik as co-counsel. Reason for request: leaving firm. (Rawnsley, Jason) (Entered: 12/15/2017)

2017-12-15

1

View

SO ORDERED - re (23 in 1:17-cv-00423-GMS) Stipulation Regarding Discovery and Further Scheduling Conference filed by Millennium Pharmaceuticals, Inc.. Signed by Judge Gregory M. Sleet on 1/10/2018. Associated Cases: 1:17-cv-00423-GMS et al. copied per paragraph 2 of this stipulation. (mdb) (Entered: 01/10/2018)

2018-01-10

1

View

Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 2/26/2018. The parties propose to consolidate these cases for one trial. A 5-day Bench Trial is set for Monday, September 30, 2019 at 9:00 AM. A proposed amended scheduling order is due by Monday, March 5, 2018. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-00423-GMS et al.(mdb)

2018-02-26

1

No Actions

Telephone Conference

2018-02-26

1

No Actions

PROPOSED ORDER -- Proposed Scheduling Order -- by Millennium Pharmaceuticals Inc., Millennium Pharmaceuticals, Inc.. (Attachments: # 1 Letter to Judge Sleet from M. Noreika enclosing order)(Noreika, Maryellen) (Entered: 03/05/2018)

2018-03-05

1

View

Remark - These cases have been consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 13-1874 (GMS). Associated Cases: 1:13-cv-01874-GMS et al.(mdb)

2018-03-14

1

No Actions

Remark

2018-03-14

1

No Actions

Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:12-cv-01490-CFC, 1:12-cv-01750-CFC, 1:13-cv-01874-CFC, 1:14-cv-00093-CFC, 1:16-cv-00223-CFC, 1:15-cv-00702-CFC, 1:17-cv-00422-CFC, 1:17-cv-00423-CFC, 1:16-cv-00998-CFC, 1:17-cv-01830-CFC (rjb) Modified on 9/20/2018 (rjb).

2018-09-20

1

No Actions

CORRECTING ENTRY: the previous entry reassigning this case to Judge Connolly had the incorrect Judge's initials in the text. Entries were corrected to reflect the below case numbers. Associated Cases: 1:12-cv-01490-CFC, 1:12-cv-01750-CFC, 1:13-cv-01874-CFC, 1:14-cv-00093-CFC, 1:16-cv-00223-CFC, 1:15-cv-00702-CFC, 1:17-cv-00422-CFC, 1:17-cv-00423-CFC, 1:16-cv-00998-CFC, 1:17-cv-01830-CFC (rjb)

2018-09-20

1

No Actions

ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before October 4, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. (Status report due 10/4/2018.) Ordered by Judge Colm F. Connolly on September 20, 2018. Associated Cases: 1:12-cv-01490-CFC et al.(nmf)

2018-09-20

1

No Actions

CASE CLOSED per D.I. 153 (Stipulation of Dismissal) in Lead Case, 13-1874-CFC. (fms)

2019-08-28

1

No Actions

Terminate Case - Civil

2019-09-16

1

No Actions

Overview

Parties

Defendant

Actavis LLC Follow

Represented By

Plaintiff

Millennium Pharmaceuticals Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

COMPLAINT filed against Actavis LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1906377) - filed by Millennium Pharmaceuticals Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 04/04/2016)

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (klc) (Entered: 04/04/2016)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 22, 2016. Date of Expiration of Patent: January 25, 2022.Thirty Month Stay Deadline: 8/22/2018. (klc) (Entered: 04/04/2016)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number: 6,713,446 B2. (klc) (Entered: 04/04/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceuticals Company Limited for Millennium Pharmaceuticals Inc. - filed by Millennium Pharmaceuticals Inc. (klc) (Entered: 04/04/2016)

SUMMONS Returned Executed by Millennium Pharmaceuticals Inc.. Actavis LLC served on 4/4/2016, answer due 4/25/2016. (Noreika, Maryellen) (Entered: 04/04/2016)

Summons Issued with Magistrate Consent Notice attached as to Actavis LLC on 4/4/2016. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (klc)

Summons Issued

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)

Case Assigned/Reassigned

ANSWER to 1 Complaint, COUNTERCLAIM against Millennium Pharmaceuticals Inc. by Actavis LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Patent/Trademark Report)(Fineman, Steven) (Entered: 04/25/2016)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Allergan plc (f/k/a Actavis plc) for Actavis LLC filed by Actavis LLC. (Fineman, Steven) (Entered: 04/25/2016)

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 4/26/2016. (asw) (Entered: 04/26/2016)

NOTICE of Appearance by Jason James Rawnsley on behalf of Actavis LLC (Rawnsley, Jason) (Entered: 05/13/2016)

MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Robyn Ast-Gmoser, Mark Deming and Khurram Naik - filed by Actavis LLC. (Rawnsley, Jason) (Entered: 05/13/2016)

ANSWER to 7 Answer to Complaint, Counterclaim by Millennium Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 05/16/2016)

SO ORDERED - re 11 MOTION for Pro Hac Vice Appearance of Attorney Gary E. Hood, Robyn Ast-Gmoser, Mark Deming and Khurram Naik filed by Actavis LLC. Ordered by Judge Gregory M. Sleet on 5/17/2016. (mdb)

SO ORDERED

Pro Hac Vice Attorney Mark T. Deming, Gary E. Hood for Actavis LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)

Pro Hac Vice Attorney Khurram Naik for Actavis LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)

Add Attorneys - PHV only

STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 9, 2016 - filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 05/25/2016)

SO ORDERED

SO ORDERED - re 13 STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 9, 2016 filed by Millennium Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 5/27/2016. (mdb)

Add Attorneys - PHV only

Pro Hac Vice Attorney Robyn H. Ast-Gmoser for Actavis LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 15, 2016 - filed by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 06/08/2016)

SO ORDERED

SO ORDERED - re 14 STIPULATION TO EXTEND TIME for the parties to file a Joint Status Report to June 15, 2016 filed by Millennium Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 6/9/2016. (mdb)

Joint STATUS REPORT [Rule 16] by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) Modified on 6/16/2016 (mdb). (Entered: 06/15/2016)

ORAL ORDER - re 15 Joint Status Report: The plaintiff's request to submit a proposed schedule by July 13, 2016 is GRANTED. Ordered by Judge Gregory M. Sleet on 6/30/2016. (mdb)

Oral Order

PROPOSED ORDER -- Scheduling Order -- by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 07/13/2016)

NOTICE OF SERVICE of Plaintiff Millennium Pharmaceuticals, Inc.'s Rule 26(a) Initial Disclosures filed by Millennium Pharmaceuticals Inc..(Noreika, Maryellen) (Entered: 09/02/2016)

NOTICE OF SERVICE of Actavis LLC's Rule 26(a) Initial Disclosures filed by Actavis LLC.(Rawnsley, Jason) (Entered: 09/02/2016)

Order Setting Teleconference AND Oral Order

~Util - Set Deadlines/Hearings AND Telephone Conference

STIPULATION Requesting Stay by Millennium Pharmaceuticals Inc.. (Noreika, Maryellen) (Entered: 10/10/2016)

SO ORDERED - re 19 Stipulation Requesting Stay. CASE STAYED. Signed by Judge Gregory M. Sleet on 10/11/2016. (mdb) (Entered: 10/11/2016)

Remark - The telephone conference set for Wednesday, October 12, 2016 at 2:00 PM has been removed from the Court's calendar. (mdb)

Remark

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Actavis LLC filed by Actavis LLC. (Rawnsley, Jason) (Entered: 10/18/2016)

NOTICE requesting Clerk to remove Robyn Ast-Gmoser as co-counsel. Reason for request: leaving firm. (Rawnsley, Jason) (Entered: 12/15/2017)

NOTICE requesting Clerk to remove Khurram Naik as co-counsel. Reason for request: leaving firm. (Rawnsley, Jason) (Entered: 12/15/2017)

Telephone Conference

PROPOSED ORDER -- Proposed Scheduling Order -- by Millennium Pharmaceuticals Inc., Millennium Pharmaceuticals, Inc.. (Attachments: # 1 Letter to Judge Sleet from M. Noreika enclosing order)(Noreika, Maryellen) (Entered: 03/05/2018)

Remark - These cases have been consolidated for all purposes. All future filings shall be made ONLY in Lead C.A. No. 13-1874 (GMS). Associated Cases: 1:13-cv-01874-GMS et al.(mdb)

Remark

CASE CLOSED per D.I. 153 (Stipulation of Dismissal) in Lead Case, 13-1874-CFC. (fms)

Terminate Case - Civil

Track Case Updates

Actavis LLC

Millennium Pharmaceuticals Inc.